Picture of Labgenomics Co logo

084650 Labgenomics Co Balance Sheet

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapFalling Star

Annual balance sheet for Labgenomics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments53,08598,898136,871115,39151,364
Net Total Accounts Receivable
Net Total Receivables31,65468,49535,55241,15439,966
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets87,526170,931174,483160,378135,567
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment7,98719,69854,88554,95757,359
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets109,364204,287250,653313,457295,662
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities25,01640,68319,89665,05576,315
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities27,82046,57141,32285,66279,348
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity81,543157,715209,331227,795216,314
Total Liabilities & Shareholders' Equity109,364204,287250,653313,457295,662
Total Common Shares Outstanding
Total Preferred Shares Outstanding